Hand-out
Press Releases
January 23, 2025
Stealth BioTherapeutics Announces PDUFA Action Date Extension for Elamipretide to Treat Patients with Barth Syndrome
– New PDUFA Action Date of April 29, 2025, Allows FDA Additional Time to Complete Review –


